IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$2.44
Tradestie Score
48
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+145.9%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.20
|
$386.68M | - | 54 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.15
|
$382.04M | - | 52 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.08
|
$371.64M | - | 52 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.55
|
$354.45M | - | 54 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$45.00
|
$353.70M | - | 50 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.07
|
$341.56M | - | 49 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.33
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.92
|
$328.62M | - | 49 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.90
|
$308.74M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.51
|
$304.12M | - | 55 | Compare |
More IKT Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry